期刊文献+

新生血管性青光眼三联序贯治疗效果观察 被引量:14

Innovative sequential treatment of neovascular glaucoma
在线阅读 下载PDF
导出
摘要 目的观察新生血管性青光眼(neovascular glaucoma,NVG)经抗血管内皮生长因子(vascular endothelial growth factor,VEGF)玻璃体内及前房内注射,小梁切除术及双目间接检眼镜下全视网膜光凝的三联序贯治疗的疗效。方法选择2014年5月至2016年5月北京大学第三医院眼科诊断为NVG伴视网膜病变且药物控制眼压不良的患者。共有18例(18眼)患者纳入本研究,其中男15例、女3例,年龄(61.7±13.9)岁。序贯治疗的第1天行前房穿刺放液联合抗VEGF前房内及玻璃体内注射,注射后3~5 d行小梁切除手术,小梁切除术术后5~7 d内开始采用双目间接检眼镜激光直视行全视网膜激光光凝。记录患者手术前后视力、眼压、角膜、虹膜、房角新生血管和眼底情况。结果视网膜中央动脉阻塞1眼,视网膜中央静脉阻塞6眼,视网膜分支静脉阻塞5眼,糖尿病视网膜病变4眼,视网膜动脉合并视网膜静脉阻塞2眼。治疗前眼压(43.5±5.1)mmHg(1 kPa=7.5 mmHg),使用抗青光眼药物种类为(5.1±0.5)种;治疗后眼压(15.2±2.2)mmHg,使用抗青光眼药物种类为(0.5±1.0)种,差异均有统计学意义(t=21.68,P<0.001;t=12.30,P<0.001)。序贯治疗后视力提高4例,视力无变化13例,下降1例。结论抗VEGF玻璃体及前房内注射,小梁切除术及双目间接检眼镜下全视网膜光凝的三联序贯治疗对NVG有明确的治疗效果。 Objective To observe the curative effects of anti-vascular endothelial growth factor (anti-VEGF) intracameral and intravitreal injection,trabeculectomy and pan-retinal photocoagulation by indirect ophthalmoscope for neovascular glaucoma (NVG).Methods NVG patients with uncontrolled intraocular pressure (IOP) and retinopathy was enrolled from May,2014 to May,2016.Eighteen patients were enrolled with 15 males(15 eyes) and 3 females(3 eyes) with age at (61.7±13.9) years old.Anti-VEGF intracameral and intravitreal injection with anterior chamber puncture was performed in the first day of sequential treatment.Trebeculectomy was performed 3-5 days after injection and finally the pan-retinal photocoagulation was started 5-7 days after anti-glaucoma surgery.The best corrected visual acuity (BCVA),IOP,cornea,neovascularization of iris and retinal disease were observed and recorded.Results The diagnosis included 1 eye with central retinal artery occlusion (CRAO),6 eyes with central retinal vein occlusion (CRVO),5 eyes with branch retinal vein occlusion,5 eyes with proliferative diabetic retinopathy and 2 eyes with combined CRAO and CRVO.IOP before and after treatment were (43.5±5.1) mmHg (1 kPa=7.5 mmHg) and (15.2±2.2) mmHg,there was significantly statistical difference (t=21.68,P〈0.001).The categories of antiglaucoma medicines were 5.1±0.5 and 0.5±1.0 before and after treatment respectively,and the difference was statistical significant (t=12.30,P〈0.001).BCVA was improved in 4 eyes,maintained in 13 eyes and decreased in only 1 eye.Conclusion The sequential treatment including anti-VEGF intracameral and intravitreal injection,trabeculectomy and pan-retinal photocoagulation by indirect ophthalmoscope is safe and effective.
出处 《眼科新进展》 CAS 北大核心 2017年第4期372-375,共4页 Recent Advances in Ophthalmology
关键词 新生血管性青光眼 小梁切除术 全视网膜光凝 neovascular glaucoma trabeculectomy pan-retinal photocoagulation
  • 相关文献

参考文献5

二级参考文献106

  • 1蒋自培,朱美玲,廖荣丰,邱翎,张晓苹.青光眼持续性高眼压下手术治疗疗效评价[J].眼科新进展,2004,24(5):376-378. 被引量:13
  • 2李苏镇.指压降压法在青光眼持续性高眼压手术时的疗效观察[J].江苏医药,1997,23(3):175-176. 被引量:3
  • 3Weiss DI, Shaffer RN, Nehrenberg TR. Neovascular glaucomacomplicating carotid-cavernous sinus fistula[ J]. Arch Ophthalmol,1963,69(2) :304-307.
  • 4Chan CK,Ip MS,Vanveldhuisen PC,Oden NL. Score study report11: Incidences of neovascular events in eyes with retinal veinocclusion[ J]. Ophthalmology,2QU,1l18 (7) ; 1364-1372.
  • 5An TS, Kwon SI. Neovascular glaucoma due to branch retinalvein occlusion combined with branch retinal artery occlusion[J]. Korean J Ophthalmol,2013 ,27(1) :64-67.
  • 6The Central Vein Occlusion Group. Natural history and clinicalmanagement of central retinal vein occlusion[ J]. Arch Ophthal-moZ,1997,115(3) :486-491.
  • 7Magargal LE,Brown GC,Augsburger JJ. Neovascular glaucomafollowing branch retinal vein obstructionf J]. Glaucoma,1996 ,3(2) :333-335.
  • 8Shiba T ’ Takahashi M,Hori Y,Saishin Y,Sato Y,Maeno T. Rela-tionship between sleep-disordered breathing and iris and/or an-gle neovascularization in proliferative diabetic retinopathy cases[J]. Am J Ophthalmol,2011,151 (4) :604-609.
  • 9Akiko G,Inatani M,Inoue T,Awal-Kasaoka N,Takihara Y,ItoY ,et al. Frequency and risk factors for neovascular glaucomaafter vitrectomy in eyes with proliferative diabetic retinopathy[J].J Glaucoma,2013 ,22(7) :572-576.
  • 10Yam^ji Y,Yoshida S,Ishikawa K,Sengoku A,Sato K, Yoshida A,et al. TEM7 (PLXDC1) in neovascular endothelial cells of fibro-vascular membranes from patients with proliferative diabeticretinopathy[ J]. Invest Ophthalmol Vis Sci,2008,49(7):3151-3157.

共引文献120

同被引文献172

引证文献14

二级引证文献385

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部